Profile data is unavailable for this security.
About the company
Modern Chinese Medicine Group Co Ltd is an investment holding company primarily engaged in the production of proprietary Chinese medicine. The Company is mainly engaged in the provision of over-the-counter and prescribed medicines intended for use by the middle-aged and the elderly. The Company’s main products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang Zheng Qi Pill, Liver-dispersing and Stomach Regulating Pill, and Fever- removing and Detoxification Pill. The intended therapeutic effects of the Company’s major products are for the treatment and alleviation of deficiency and blood-stasis condition, cardio-cerebrovascular condition, digestive and gastrointestinal condition, and gynaecological condition. The Company mainly conducts its businesses within domestic market.
- Revenue in HKD (TTM)229.78m
- Net income in HKD21.56m
- Incorporated2019
- Employees190.00
- LocationModern Chinese Medicine Group Co LtdNo. 88 Jinwei RoadCHENGDE ChinaCHN
- Websitehttps://www.cdysjdyy.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 644.89m | 504.00 | 7.09 | 1.68 | 5.63 | 1.09 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.28bn | 23.36m | 656.34m | 2.49k | 27.45 | 0.5319 | 4.54 | 0.2878 | 0.0277 | 0.0277 | 2.70 | 1.43 | 1.05 | 2.66 | 6.45 | 884,979.90 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Fusen Pharmaceutical Co Ltd | 273.87m | -198.85m | 731.91m | 1.05k | -- | 1.86 | -- | 2.67 | -0.269 | -0.269 | 0.3704 | 0.5327 | 0.1875 | 1.11 | 4.05 | 242,146.20 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Pak Fah Yeow International Ltd | 199.03m | 70.97m | 754.17m | 100.00 | 10.63 | 1.07 | 9.72 | 3.79 | 0.2277 | 0.2277 | 0.6386 | 2.26 | 0.2227 | 1.84 | 24.74 | 1,877,594.00 | 7.94 | 5.03 | 8.68 | 5.24 | 87.44 | 82.23 | 35.66 | 23.92 | 6.21 | 7.72 | 0.0068 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Lee's Pharmaceutical Holdings Ltd | 1.44bn | 97.81m | 783.15m | 1.04k | 8.01 | 0.403 | 3.89 | 0.5452 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| Transcenta Holding Ltd | 10.69m | -302.69m | 872.79m | 171.00 | -- | 1.07 | -- | 81.64 | -0.747 | -0.747 | 0.0264 | 1.81 | 0.0075 | 0.3793 | 0.4927 | 58,105.23 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 981.22m | 49.00 | 25.00 | 0.8059 | -- | 25.76 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| 3D Medicines Inc | 509.56m | -191.49m | 1.01bn | 183.00 | -- | 1.24 | -- | 1.99 | -0.7816 | -0.7816 | 2.08 | 3.15 | 0.3728 | 7.53 | 6.78 | 2,667,843.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Modern Chinese Medicine Group Co Ltd | 229.78m | 21.56m | 1.02bn | 190.00 | 39.51 | 1.54 | 29.25 | 4.45 | 0.0359 | 0.0359 | 0.383 | 0.9196 | 0.392 | 5.89 | 7.49 | 1,209,393.00 | 3.68 | 14.83 | 3.93 | 17.56 | 24.57 | 38.44 | 9.38 | 17.92 | 7.80 | 21.30 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 207.93m | 1.15bn | 798.00 | 5.52 | 0.5833 | 4.76 | 1.09 | 0.3712 | 0.3712 | 1.88 | 3.51 | 0.3698 | 2.30 | 3.34 | 1,413,930.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.33bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
